Pembrolizumab and Chemotherapy in Newly-Diagnosed, Early Unfavorable or Advanced Stage Classic Hodgkin Lymphoma: The Phase 2 Keynote-C11 Study Advani, R. H., Avigdor, A., Sureda, A., Lavie, D., Hohaus, S., Zaucha, J. M., Vu Minh Hua, Zilioli, V., Gazitua, R., Ozcan, M., Odeleye-Ajakaye, A., Ogbu, U. C., Nahar, A., Winter, J. N. AMER SOC HEMATOLOGY. 2022: 1759-1760

View details for DOI 10.1182/blood-2022-163787

View details for Web of Science ID 000893223201317